Back to your search result

TRC-B675700-10MG
Item no.
TRC-B675700-10MG
CAS Number
[179324-69-7]
Unit
10 mg
Molecular formula
C19H25BN4O4
Molecular weight
384,24
Shipment details
No Dangerous Good /not restricted

Description

Category: Chiral Reagents, Boron Derivatives, Inhibitors, Pharmaceuticals, Intermediates and Fine Chemicals /// Appearance: White to Off-White Solid /// Application Notes: Bortezomib is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway. /// References: Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005)| Drahl C.: Chem. and Eng. News, 87, 41 (2009)

Structure formula

Bortezomib

Contents

Miscellaneous

Certificate of Analysis (specimen)

Reference Material CoA specimen: for the current lot, please contact your customer service representative at info@labmix24.com

Product data sheet

View all available product details e.g. description, analytes/parameters, CAS Number, concentrations/values, sales unit/product format, method, source, transport information

TRC | Toronto Research Chemicals

Quality analytical standards and reference materials for food and environmental analysis, research

Founded in 1982, Toronto Research Chemicals is specialized in the development and production of reference materials used in research as well as food safety testing and environmental analysis. The range of more than 350,000 products includes reference standards for pesticides and metabolites, impurities, natural compounds and complex organic small molecules not otherwise commercially available.